SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

Bullboard Posts

Comment by FactFinder1994on Mar 05, 2018 8:59am

83 Views

Post# 27660192

RE:A billion $ opportunity?

Like your math here, but have to say it is conservative over the long haul. Margins here run on high. You spoke to $1.20 of revenue per share based on the conservative scenario, but keep in mind that gross margin in that scenario would be about a buck a share! Now you haven't even started to layer any other business on. I know, it is pretty incredible math isn't it.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023